GO-Pen
Financiado
The first universal and price-neutral insulin pen
The challenge for many people with diabetes (PwD) is that they don’t get the right dose of insulin at the right time. This can potentially give long term health issues, and even shorten their lifetime. Today, this is an everyday c...
The challenge for many people with diabetes (PwD) is that they don’t get the right dose of insulin at the right time. This can potentially give long term health issues, and even shorten their lifetime. Today, this is an everyday challenge for more than 13 million people that still inject insulin with a 100 year’s old outdated technology (syringes and needles) and cannot afford branded insulin and modern pens. GO-Pen ApS developed the 1st affordable, safe, and sustainable insulin injection system that fits the unmet health needs in the world’s most resource constrained population. The UNIPEN system innovation relies on the possibility of refilling a disposable cartridge with any kind of insulin available, resulting in a cost-competitive device to syringes solution improving the accuracy. Now, with the support of the EIC-A funding, we intend to refine the design of the UNIPEN device, demonstrate its design and clinical usability, and fine-tune the scale-up production.
ver más
Duración del proyecto: 26 meses
Fecha Inicio: 2022-12-15
Fecha Fin: 2025-02-28
Fecha Fin: 2025-02-28
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-15
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2022-ACCELERATOROPEN-01:
EIC Accelerator Open
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
5M€
Líder del proyecto
GOPEN APS
No se ha especificado una descripción o un objeto social para esta compañía.
